What is Ultrahuman Ring?

Ultrahuman Ring: market-access-redesigned ring archetype

Ultrahuman Ring (Air / Pro) is a hardware + subscription-augmented smart ring biometric from Ultrahuman. Per DEPLOY's biometric cluster framework, Ultrahuman Ring anchors the market-access-redesigned ring archetype within the ring sub-cohort: a within-entity verified-vs-claimed editorial throughline where product + AI exist globally but US market access was blocked then restored via patent-redesign.

---

Co-founder: Vatsal Singhal (CORRECTED from Vatsal Kumar)

Per Agent A Wave 2 biometric ingest, Ultrahuman was co-founded by Vatsal Singhal (NOT Vatsal Kumar). Per DEPLOY's framework, the founder-name correction matters editorially at the entity verification layer: trade-press coverage citing Vatsal Kumar operates outside Agent A primary-source-anchored verification. The Vatsal Singhal correction is the load-bearing founder-identification primary source.

---

US market access: blocked October 21, 2025 → restored March 24, 2026 via Ring Pro unibody redesign

Per Agent A Wave 2 biometric ingest, the US market access saga requires precise dating + scope:

• Blocked: October 21, 2025, via Oura ITC '178 patent ruling. The ITC final determination effective date was August 2025; the import ban + customs enforcement took effect October 21, 2025.
• Restored: March 24, 2026, via Ring Pro unibody redesign cleared US Customs. The redesigned hardware (avoiding the '178 patent claims) cleared US Customs March 24 2026 and Ultrahuman regained US market access.
• Federal Circuit appeal pending; stay denied (so the redesign-path restoration operates as the load-bearing US market access mechanism; appeal-outcome restoration remains a forward question).

Per cap-flag-as-trust-signal, the blocked-then-restored framing is the load-bearing verified scope; trade-press coverage that frames Ultrahuman at uniformly-blocked or uniformly-available verification posture operates outside Agent A primary-source-anchored verification.

Per DEPLOY's framework, the saga parallels the Apple SpO2 feature-scope disabled-then-restored editorial throughline: same within-entity verified-vs-claimed framework operating at the US-import vs feature-disable layer; both restored via patent-design-around (Apple via Series 10 + earlier redesigns; Ultrahuman via Ring Pro unibody). The patent-design-around-as-restoration pattern is editorial signal at the cohort-architecture layer.

---

AFib detection via FibriCheck (NOT native FDA-cleared)

Per Agent A Wave 2 biometric ingest, Ultrahuman Ring's AFib detection routes via FibriCheck third-party app integration, NOT native FDA-cleared on-device detection. The FibriCheck integration provides AFib screening through a third-party medical device app; the AFib capability is NOT a native Ultrahuman FDA clearance.

Per cap-flag-as-trust-signal, the FibriCheck-vs-native AFib distinction matters editorially: trade-press coverage that frames Ultrahuman as having native FDA-cleared AFib detection operates outside Agent A primary-source-anchored verification. The native-vs-third-party-app distinction is editorial signal at the FDA-clearance verification layer within the biometric cluster.

---

Commercial model: hardware + subscription-augmented

Per Agent A Wave 2 biometric ingest, Ultrahuman Ring operates a hardware purchase + subscription-augmented commercial model: approximately ~$349 Ring Air hardware purchase with premium features requiring subscription (Ring Pro pricing operates per current public-list verification). Distinct from RingConn subscription-free + Oura purchase+membership + Whoop subscription-only commercial models.

Per DEPLOY's framework, the subscription-augmented archetype occupies a distinct position within the ring sub-cohort's commercial-model layer: hardware purchase as primary commercial commitment + subscription as feature-tier expansion (vs RingConn all-features-included + Oura distinct-membership-fee + Whoop subscription-only-data-access).

---

Ring Pro as US-redesign variant (alias, not separate entity)

Per Agent A Wave 2 biometric ingest + slug audit, the Ultrahuman Ring registry entity scope is modelName "Ultrahuman Ring (Air / Pro)": the Ring Pro is covered as a US-redesign variant within the same entity record (alias, not separate entity). The Ring Pro represents the patent-redesign restoration mechanism for US market access; both Ring Air + Ring Pro share the underlying Ultrahuman entity scope.

Per DEPLOY's slug-discipline pattern, the line-level entity scope is editorially appropriate: the Ring Pro is a market-access-redesign variant of the same product line, not a structurally distinct entity. The line-level scope preserves cohort framework boundary while documenting the within-entity verified-vs-claimed throughline.

---

Cohort positioning: market-access-redesigned ring archetype

Per the biometric cluster framework, Ultrahuman Ring anchors:

• Market-access-redesigned ring archetype: US blocked Oct 21 2025 → restored Mar 24 2026 via Ring Pro unibody redesign; patent-design-around-as-restoration pattern.
• Hardware + subscription-augmented commercial model: ~$349 Ring Air + subscription-tier premium features.
• FibriCheck-vs-native AFib distinction: AFib detection via third-party app integration, NOT native FDA-cleared.
• Line-level entity scope: Ring Air + Ring Pro within single modelName "Ultrahuman Ring (Air / Pro)."

Contrast with cohort:

• RingConn (Gen 2 / Gen 3): subscription-free ring; ITC settled-licensed (NOT blocked); AHI 90.7%-claimed not FDA-cleared.
• Happy Ring: FDA-cleared + service-gated ring; dual K240236 + K242224 clearances.
• Oura Ring: purchase+membership commercial model; '178 patent holder; plaintiff in ITC dispute.
• Whoop: subscription-only band cohort exemplar; ~$478 Year 1 effective cost.

For the canonical biometric cluster context, see the biometric cluster. For the within-cohort verified-vs-claimed counterpoints, see what is RingConn (ITC settled-licensed) and what is Happy Ring (dual FDA clearances). For the canonical category umbrella, see what is physical AI. For methodology canonical references applicable to Ultrahuman: verified-vs-claimed at within-entity granularity (CANONICAL excluded-then-restored verification trajectory within Oura '178 patent ITC family) + the 9-tier source-quality rubric (ITC exclusion + restoration primary-government-record source classification).